• Fasudil (HA-1077) HCl: Dissecting ROCK Inhibition for Cell F

  2026-06-08

  Explore the multi-faceted role of Fasudil (HA-1077) HCl as a selective ROCK inhibitor in controlling cell proliferation, migration, and apoptosis. This article provides a deeper mechanistic and practical perspective for advanced assay optimization, distinguishing itself from prior coverage.

• Vitamin C as an Anticancer and Antiviral Agent: Organoid Wor

  2026-06-08

  Vitamin C (ascorbic acid) is redefining cancer and antiviral research, enabling precise modulation of apoptosis and tumor cell proliferation in advanced organoid and in vivo models. This article distills stepwise workflows, protocol enhancements, and troubleshooting strategies for leveraging high-purity Vitamin C (CAS 50-81-7) from APExBIO in translational research.

• Fangchinoline Enhances TFEB-Driven Lysosomal Biogenesis Agai

  2026-06-07

  Cheng et al. reveal that fangchinoline restores TFEB-mediated lysosomal biogenesis, counteracting H1N1 influenza virus strategies that impair host cell degradation pathways. These findings identify lysosomal modulation as a promising antiviral strategy and provide a detailed mechanistic framework for host-directed influenza research.

• EdU Imaging Kits (488): Precision Cell Proliferation Assays

  2026-06-06

  EdU Imaging Kits (488) harness click chemistry for sensitive, morphology-preserving cell proliferation analysis, outperforming traditional BrdU methods. This guide translates best practices and troubleshooting insights from cutting-edge research to help you optimize DNA synthesis detection in S-phase studies.

• Desert lncRNA HIDEN Orchestrates Endoderm Differentiation vi

  2026-06-05

  Lu et al. reveal a pivotal role for the desert lncRNA HIDEN in human endoderm differentiation by facilitating IMP1 interaction with FZD5 mRNA and stabilizing WNT signaling. This study establishes desert lncRNAs as essential regulators in stem cell fate, opening new avenues for dissecting noncoding RNA functions in developmental biology.

• HAUS1 as an Immune-Linked Prognostic Biomarker in HCC

  2026-06-05

  This study identifies HAUS1 as a highly expressed gene in hepatocellular carcinoma (HCC) that correlates with poor prognosis and altered immune microenvironment. Through integrative bioinformatics and in vitro assays, the research highlights HAUS1's role in cell proliferation, invasion, and immune modulation, proposing it as a potential diagnostic and therapeutic target.

• Magnetic Bispecific Nano-Antibodies Enable In Vivo CAR-T Mim

  2026-06-04

  This study presents a novel strategy for generating and guiding CAR-T-mimicking cells in vivo using magnetic bispecific nano-antibodies. The approach addresses key limitations in current solid tumor immunotherapies by enabling direct endogenous T cell engineering and magnetic navigation, with compelling preclinical antitumor efficacy.

• FCCP: Strategic Leverage for Translational Mitochondrial Res

  2026-06-04

  This thought-leadership article offers translational researchers a mechanistic and strategic roadmap for using FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) to interrogate mitochondrial function, disrupt hypoxia signaling, and drive innovation in cancer and metabolic regulation research. Integrating robust experimental evidence, competitive insights, and forward-looking guidance, it positions APExBIO’s FCCP as a pivotal tool for advancing the frontiers of cellular metabolism and therapeutic discovery.

• Dual-Metric In Vitro Evaluation Refines Cancer Drug Assessme

  2026-06-03

  Schwartz's dissertation introduces a dual-metric in vitro framework distinguishing proliferative arrest from cell death for evaluating anti-cancer drug responses. This methodological advance allows for more nuanced interpretation of drug efficacy and supports optimized design of preclinical cancer research protocols.

• Strategic Use of Cucurbitacin I for Translational STAT3 Rese

  2026-06-03

  This thought-leadership article dissects the mechanistic power and translational strategy surrounding Cucurbitacin I (JSI-124) as a selective STAT3 pathway inhibitor. Bridging cutting-edge cancer biology with protocol guidance, it equips translational researchers to exploit this tool for high-impact studies on tumor biology and therapy sensitization. The article situates Cucurbitacin I within a competitive landscape, highlights its unique mechanistic attributes, links to advanced human cardiac research models, and offers a visionary perspective on its future role in translational science.

• Nystatin (Fungicidin): Synergy, Resistance, and Next-Gen Ant

  2026-06-02

  Explore how Nystatin (Fungicidin) is redefining antifungal research through synergy with novel agents and advanced model systems. This article offers a unique, evidence-based perspective on overcoming resistance and optimizing experimental design with Nystatin.

• Ultrafiltration Enables High-Purity Circular RNA Isolation

  2026-06-02

  Guillen-Cuevas et al. introduce an ultrafiltration-based method for purifying circular RNA (circRNA), achieving significantly greater purity and yield than conventional approaches. This advance addresses a major bottleneck in circRNA therapeutic development by enabling scalable, efficient separation from linear RNA contaminants.

• Acacetin-Mediated MAPK1/HMOX1 Axis in IVDD: Study Insights

  2026-06-01

  This study uncovers a novel mechanism by which Duhuo Jisheng Decoction (DHJS) and its active compound acacetin alleviate intervertebral disc degeneration (IVDD) through regulation of the MAPK1/HMOX1 axis, enhancing mitophagy and suppressing pyroptosis in nucleus pulposus cells. The findings advance understanding of mitophagy–pyroptosis crosstalk and provide a scientific basis for targeted therapies in degenerative disc disease.

• MAPK10 Drives KRT16 Degradation to Suppress NSCLC Metastasis

  2026-06-01

  This study elucidates a phosphorylation-dependent pathway in which MAPK10 suppresses non-small cell lung cancer (NSCLC) metastasis by targeting keratin 16 for ubiquitination and degradation. The findings highlight the prognostic and therapeutic significance of the MAPK10/KRT16/RNF213 axis, providing a refined molecular framework for personalized NSCLC interventions.

• Bleomycin Sulfate (A8331): Reliable Data for Fibrosis & DNA

  2026-05-31

  This article addresses common lab challenges in modeling DNA damage and pulmonary fibrosis, demonstrating how Bleomycin Sulfate (SKU A8331) enables reproducible, data-backed results. Scenario-driven Q&A blocks provide evidence-based guidance on protocol design, data interpretation, and product selection, grounded in peer-reviewed literature and validated workflows.

16231 records 1/1083 page Next 12345 下5页 Last page